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ABSTRACT
We have had some important improvements in the intensive 
care units (ICU) like  high flow oxygen system (HFOS), 
therapeutic hypothermia, extra corporeal membrane oxygenation 
(ECMO), extra corporeal carbon dioxide removal (ECCOR), 
echocardiography (ECHO) and ultrasonography (US).  
HFOS gives oxygen to the patients at rates of flow higher (up 
to 60 L/min) than that delivered traditionally in LFOS (up to 16L/
min). It is obtained 1 cmH2O PEEP for every 10L/min of flow 
delivered by HFOS. HFOS serves as an important alternative to 
noninvasive mechanical ventilation especially in the management 
of the patients with hypoxemic respiratory failure.
Post-resuscitation care consists of optimization of oxygenation 
and ventilation, avoiding hypotension, treating immediate 
precipitants of cardiac arrest such as acute coronary ischemia 
and initiating therapeutic (induced) hypothermia. Therapeutic 
hypothermia decreases cerebral metabolic rate, blood volume, and 
intracranial pressure, prevents reperfusion injury. So hypotermia 
protects cerebral functions.
ECMO, the type of cardiopulmonary support, has become an 
essential tool in critical care patients with severe respiratory and 
cardiac failure, refractory to conventional therapy methods.
Critical care ultrasonography (CCUS) and echocardiography 
have utility for intensivist-performed, immediate diagnoses of life 
threatening diseases, with no need to  transport patients to radiology 
or cardiology departments or wait for radiologist or cardiologist on 
a consultative basis. CCUS and echocardiography should be 
an essential part of training of every ICU physician.
Keywords: Intensive Care Units,  Oxygen inhalation therapy; 
Extracorporeal membrane oxygenation; Extra corporeal carbon 
dioxide removal; Hypothermia, Induced; Echocardiography; 
Ultrasonography
High flow oxygen system 
Traditionally, oxygen delivery systems can be classified 
as low flow oxygen system (LFOS) and high flow oxygen 
system (HFOS). If the patient’s respiratory demand is met 
completely by the system, the system is called as high flow 
oxygen system such as venturi mask. If the patient ventilator 
demand cannot meet by the oxygen delivery system, the 
system is called as low flow oxygen system such as nasal 
cannula, simple mask (Table I).
Table I.  Comparison of Low-Flow and High-Flow Oxygen Systems
LOW FLOW
OXYGEN SYSTEMS
HIGH FLOW
OXYGEN 
SYSTEMS
Patient’s all 
respiratory 
requirements
Cannot meet, part of the 
VT must be supplied by 
breathing room air
Meet
Examples Nasal cannula, simple 
mask, mask with 
reservoir bag (partial or 
non-rebreathing mask)
Venturi mask, 
face tent, aerosol 
mask, T piece 
tracheostomy 
collar
Constant and 
predictable FiO2
May not provide Provide
Change in patient 
ventilator pattern
Affect FiO2 Does not affect 
FiO2
Reservoir 
capacity
Affect FiO2 Does not affect 
FiO2
Cost Cheap Expensive
It is accepted that the adult patient whose tidal volume is 
between 300-700 mL and whose respiratory rate below 25/
min and whose ventilatory pattern is regular may use LFOS, 
because the patient will receive consistent and predictable 
FiO2 on a LFOS. If any one of these three criteria is not met, 
the patient should be on HFOS.
HFOS gives oxygen to the patients at rates of flow higher 
(up to 60 L/min) than that delivered traditionally in LFOS (up 
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to 16L/min). Oxygen flow only shows total gas flow, does not 
show FiO2. FiO2 delivered by an oxygen flow is determined 
by the apparatus and the patients. So it can be also got high 
FiO2 by using LFOS such as mask plus reservoir bag.
The high gas inlet flow prevents secondary room-
air entrainments. So, all of the patient’s respiratory 
requirements can be met by HFOS. The air is warmed to 
37 °C and humidified. Humidification prevents mucus 
plugging. Mucociliary function remains well. The warmed 
and humidified oxygen can be better tolerated by the patient, 
so patient comfort increases.
High flow washes out CO2 in anatomic dead space; create 
high FiO2 in the anatomic reservoir (nasal cavity, nasopharynx 
and oropharynx). The warm, humidified constant flow 
improves gas exchange and reduces respiratory work. PEEP 
can be generated by HFOS. It is obtained 1 cmH2O PEEP for 
every 10 L/min of flow delivered by HFOS. This may help to 
prevent and/or decrease atelectasis [1].
HFOS serve as an important alternative to noninvasive 
mechanical ventilation especially in the management of the 
patients with hypoxemic respiratory failure. Noninvasive 
mechanical ventilation cannot be used in patients with facial, 
esophageal or gastric surgery, impaired swallowing and 
cough. A high flow oxygen system uses special nasal cannula 
thus HFOS does not interfere with eating and speaking. If 
the patient receives FiO2 of greater than 60% and more than 
48 hours, the patient may at risk of oxygen toxicity. Positive 
pressure ventilation improves oxygenation and CO2 removal 
by alveolar recruitment, increasing alveolar volume and 
redistribution of extracellular lung water, So it is reasonable 
to use positive pressure in the patient on high O2 like this 
level (Figure 1) [2]. 
Figure 1. Positive pressure ventilation improves gase exchange. 
A-Alveolar recruitment, B-Increasing alveolar volume, 
C-Redistribution of extravascular lung water.
HFOS contains blender connected to the wall outlet, a 
humidifier, heated tubing and nasal cannula (Figure 2).
Figure 2. Schematic representation of a High-Flow Oxygen System
Epistaxis, base of skull fracture, surgery to the nose or upper 
aero-digestive tract, nasal obstruction; e.g. nasal fracture, 
tenacious secretions, tumor are main contraindications for 
HFOS therapy.
High-flow oxygen has been shown to result in better 
comfort and oxygenation than standard oxygen therapy 
delivered through a face mask in patients with acute 
respiratory failure of various origins. In acute cardiogenic 
pulmonary edema, providing low levels of PEEP, HFOS 
proposed to function as CPAP through opening collapsed 
alveoli and enhancing cardiac function through afterload 
reducing effect of PEEP. A cohort study showed promising 
results [3]. In postoperative hypoxemic respiratory failure 
HFOS have shown improved oxygenation, reduced 
respiratory rate and need for noninvasive mechanical 
ventilation[4-6]. Two randomized trials comparing standard 
oxygen therapy and HFOS have shown a better patient 
comfort but no significant difference in gas exchange in 
post-extubation patients [7, 8]. Two retrospective analysis 
of HFOS in Do-Not-Intubate patients with cancer and 
respiratory distress have shown that nearly 85% of patients 
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treated with HFOS improved or remained stable but 18% of 
patients still needed escalation of therapy to NIMV [9, 10].
It has been reported that treatment with high-flow 
oxygen improved the survival rate among patients with 
acute hypoxemic respiratory failure, as compared with 
standard oxygen therapy or NIMV. The hazard ratio for 
death at 90 days was 2.01 (95% confidence interval (CI), 
1.01 to 3.99) with standard oxygen versus high-flow oxygen 
(p=0.046) and 2.50 (95% CI, 1.31 to 4.78) with NIMV 
versus high-flow oxygen (p=0.006).Intubation rates were 
not significantly different among three groups (38% in the 
high flow O2 group, 47% in the low flow O2 group and 50% 
in the NIMV group [11].A prospective trial in patients with 
hypoxemic respiratory failure, HFOS applied sequentially 
with non-invasive mechanical ventilation (NIMV) and 
shown that HFOS improved oxygenation but not as much as 
NIMV compared to standard oxygen therapy [12].
In conclusion, HFOS have become standard care in 
several clinical situations for infants, children and preterm 
neonates. It has a number of physiologic benefits over 
conventional therapy such as greater comfort and tolerance, 
improved oxygenation. So it is gaining clinical use in adult 
population. 
Therapeutic hyperthermia
Therapeutic hypothermia after cardiac arrest
Cardiac arrest is a catastrophic, life threatening event. 
Survival and neurologic recovery vary widely. Fortunately 
over the last decade there are improvements in survival 
and neurologic outcomes due to increased education and 
awareness of basic cardiac life support and may be more 
importantly concept of post-resuscitation care. 
Post-resuscitation care consists of optimization of 
oxygenation and ventilation, avoiding hypotension, treating 
immediate precipitants of cardiac arrest such as acute 
coronary ischemia and initiating therapeutic (induced) 
hypothermia (TT or IT). Current guidelines uses the term 
“Targeted Temperature Management” (TTM) [13-15].
During cardiac arrest, hypoxia and eventually anoxia 
develops. In brain tissue, within minutes ATP and glucose 
are depleted and cells lose their integrity. This results 
in apoptosis. Restoration of oxygenation as a result of 
successful resuscitation stops anoxic injury but death 
form reperfusion injury occurs. Reperfusion injury is a 
result of increased reactive oxygen species and with other 
inflammatory cascades further aggravates endothelial and 
vasomotor dysfunction, edema, hypoxia at tissue-level 
in spite of adequate arterial oxygenation, and sequential 
neurological damage. Hypothermia slowdown inflammatory 
cascade and inhibits apoptosis pathways by downregulating 
excitatory amino acids and free radicals. Also, hypothermia 
decreases cerebral metabolic rate, blood volume, and 
intracranial pressure [16]. 
The Hypothermia After Cardiac Arrest Study Group 
have shown that in patients who have been successfully 
resuscitated after cardiac arrest due to ventricular 
fibrillation, therapeutic mild hypothermia increased the rate 
of a favorable neurologic outcome and reduced mortality. 55 
% of patients had better neurologic outcome and mortality at 
six months was 41 % in the hypothermia group as compared 
with 55 % in the normothermia group (RR: 0.74; 95 % CI: 
0.58 - 0.95) [17]. Also another trial on comatose survivors 
of out-of-hospital cardiac arrest suggests that treatment with 
moderate hypothermia appears to improve outcomes in 
patients. 49 % patients treated with hypothermia survived 
and had a good outcome as compared with 26 % treated with 
normothermia (p=0.046). The odds ratio for a good outcome 
with hypothermia as compared with normothermia was 5.25 
(95 % CI: 1.47 - 18.76; P=0.011) [18].
On the basis of these 2 studies, TH/IH/TTM is now 
considered standard of care in the treatment of patients 
successfully resuscitated from a ventricular tachycardia 
(VT/VF) arrest and is recommended as a reasonable option 
for patients with CA from a non-shockable rhythm.
Current practice guideline recommendations of The 
American Heart Association, the International Liaison 
Committee of Resuscitation, and the European Resuscitation 
Council are summarized in Table II.
Therapeutic hypothermia after traumatic brain injury
Fever aggravates outcome after stroke and head injury, 
probably by worsening secondary brain injury [19]. TH has 
become an experimental treatment for traumatic brain injury 
due to its intracranial pressure reducing and neuroprotective 
effect [20]. A systematic review of TH following traumatic 
brain injury has indicated a small decrease in mortality (RR 
0.76, 95% CI 0.60-0.97) or poor neurologic outcome (RR 
0.69, 95% CI 0.55-0.86) [21]. Later reviews found parallel 
results for death and neurologic outcome as well as an 
increased risk for pneumonia [20, 22-26].
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Therapeutic hypothermia in acute liver failure
Cerebral edema is a rare but fatal complication of acute liver 
failure. Its incidence increases with grade of encephalopathy 
and nearly 75 % of patients with grade IV encephalopathy 
have cerebral edema [27]. Cerebral edema leads to the 
most common causes of death in acute liver failure which 
are elevated intracranial pressure, brain ischemia, and 
brainstem herniation [28]. Liver transplantation remains the 
only definitive treatment option for cerebral edema. Animal 
models of liver failure have shown that hypothermia decreases 
cerebral edema [29]. A systematic review of case series has 
shown that induction of moderate hypothermia may have a 
benefit but only with intracranial pressure monitoring [30]. 
However, more recent studies have had variable results [31, 
32]. In spite of the potential beneficial effects, hypothermia 
can also increase the risk of infection, cardiac dysrhythmias 
and bleeding [33]. Consequently, more studies are needed 
before TH/IH/TTM can be routinely used. However, it is a 
reasonable option as a bridge to transplantation as we used 
previously successfully in our center [34].
TH consists of 4 stages: initiation, maintenance, 
rewarming and return to normothermia (Figure 3). There are 
multiple methods to induce and maintain TH [35].
American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
•	 comatose (ie, lack of meaningful response to verbal commands) adult patients with ROSC after cardiac arrest should have TTM 
(Class I, LOE B-R for VF/pVT OHCA; Class I, LOE C-EO for non-VF/pVT (ie, “nonshockable”) and in-hospital cardiac arrest).
•	 selecting and maintaining a constant temperature between 32°C and 36°C during TTM (Class I, LOE B-R)
•	 maintained for at least 24 hours after achieving target temperature (Class IIa, LOE C-EO)
•	 We recommend against the routine prehospital cooling of patients after ROSC with rapid infusion of cold intravenous fluids 
(Class III: No Benefit, LOE A)
•	 reasonable to actively prevent fever in comatose patients after TTM (Class IIb, LOE C-LD).
European Resuscitation Council Guidelines for Resuscitation
•	 TTM is recommended for adults after OHCA with an initial shockable rhythm who remain unresponsive after ROSC (strong 
recommendation, low-quality evidence)
•	 TTM is suggested for adults after OHCA with an initial non-shockable rhythm who remain unresponsive after ROSC (weak 
recommendation, very low-quality evidence).
•	 TTM is suggested for adults after IHCA with any initial rhythm who remain unresponsive after ROSC (weak recommendation, 
very low-quality evidence)
•	 Maintain a constant, target temperature between 32 0C and 36 0C for those patients in whom temperature control is used (strong 
recommendation, moderate-quality evidence)
•	 If targeted temperature management is used, it is suggested that the duration is at least 24 h (weak recommendation, very low-
quality evidence).
International Liaison Committee on Resuscitation
•	 We recommend targeted temperature management as opposed to no targeted temperature management for adults with OHCA 
with an initial shockable rhythm who remain unresponsive after ROSC (strong recommendation, low-quality evidence).
•	 We suggest targeted temperature management for adults with OHCA with an initial nonshockable rhythm who remain 
unresponsive after ROSC (weak recommendation, low-quality evidence).
•	 We suggest targeted temperature management for adults with IHCA with any initial rhythm who remain unresponsive after 
ROSC (weak recommendation, very low-quality evidence).
•	 We recommend selecting and maintaining a constant target temperature between 32°C and 36°C for those patients in whom 
targeted temperature management is used (strong recommendation, moderate-quality evidence).
“ROSC: return of spontaneous circulation; TTM: therapeutic temperature management; VF: ventricular fibrillation; pVT: pulseless 
ventricular tachycardia; OHCA: Out of Hospital Cardiac Arrest; IHCA: In Hospital Cardiac Arrest; LOE: level of evidence; ”
Table II. Summary of Practice Guideline Recommendations for Therapeutic Hypothermia
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Figure 3. Stages of hypothermia. BP indicates blood pressure; K+, 
serum potassium concentrations; spO2, oxygen saturation.
Conventional Cooling Systems: Ice bags and cold saline 
infusion are the easiest and cheapest ways to induce 
hypothermia. They have been shown to be effective in 
inducing hypothermia but not in maintenance [36]. Also 
they can be used with other cooling methods [37]. But most 
important disadvantage of these systems is the uncontrolled 
cooling which may result in body temperatures below target 
range.
Surface Cooling Systems: Circulating cold air or cold 
fluids inside blankets or pads surrounding body is an 
effective way of cooling. Advantages include ease of use 
and rapid initiation of treatment. Also these systems have 
a computer controlled feedback system and allows user to 
interfere according to trends. Possible disadvantage of these 
systems is that skin burns and irritations. Shivers also seen 
more commonly [35].
Internal Cooling Systems: These systems use central 
venous catheters through which cool or warm saline 
circulates in a closed loop. By means of heat exchange 
with blood catheters achieve hypothermia and maintain it 
precisely. In spite of these advantages, compared to surface 
cooling there is no significant difference in outcome [38].
Extra Corporeal Membrane Oxygenation (ECMO) 
and Extra Corporeal Carbon Dioxide Removal 
(ECCOR)
ECMO has become an essential tool in critical care patients 
with severe respiratory and cardiac failure, refractory to 
conventional therapy methods.
The first heart-lung machine was used for cardiovascular 
surgery in 1953[39]. Soon after successful use of 
extracorporeal membrane oxygenation (ECMO) outside the 
operating room was reported in 1972, by Robert Bartlett 
[40]. This work led to technologic innovations and use 
of extracorporeal life support (ECLS) in management of 
patients with severe acute respiratory distress syndrome 
(ARDS). 2009 to 2010 influenza (H1N1) pandemics resulted 
in an increasing use of ECLS for cardiopulmonary failure 
after traditional treatment options have failed [41].
ECMO is a type of cardiopulmonary support, where 
blood is drained from the vascular system via cannula 
connected to a mechanical circuit outside the body and then 
reinfused into the circulation with oxygenation and removal 
of pCO2.
Depending on indications there are two types of 
ECMO with cardiopulmonary (venoarterial VA-ECMO) 
or pulmonary support (venovenous VV-ECMO). Support 
can work partially or completely by preference. A typical 
circuit is composed of cannulas and tubing, a membrane 
or oxygenator, a blood pump and a heat exchanger. Venous 
blood drained from a major vein, passes through a pump 
and a membrane for gas Exchange and then returns a major 
artery (VA-ECMO) or vein (VVECMO) fully saturated with 
oxygen through an oxygenator, cleaned from CO2 via a 
membrane heated by an exchanger (Figure 4).
Figure 4. Essential components of extracorporal support systems. 
Venoarterial systems support heart and lung, venovenous systems 
support lung during ECMO. ECCOR (venovenous, lower blood 
flow rates system with or without pump) supports only lung
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ECCOR is provided to remove CO
2
 and, unlike ECMO, 
does not provide significant oxygenation. In contrast to 
ECMO, where the need for oxygenation requires high 
blood flow rates, ECCOR allows much lower blood flow 
rates (500-1000mL/min) and needs smaller access cannulas. 
So, ECCOR promises to improve safety and ease of use. 
If the patient has sufficient arterial pressure (arteriovenous 
pressure gradient ≥ 60 mm Hg), a pumpless system may 
be used in ECCOR. Otherwise, we have to use mechanical 
pump [42].
Vascular access and management
VA is preferred if cardiac function is depressed and cardiac 
support is also required. Patients with severe respiratory 
failure and secondary cardiac failure may improve on VV 
support alone. VV access may be by femoral and jugular 
veins with 2 cannulas or a double lumen cannula via only 
jugular vein [43].
VA access may be central with intrathoracic cannula 
through ascending aorta in postcardiotomy and percutaneous 
peripheral with femoral artery to femoral vein or femoral 
artery to jugular vein in non-postcardiotomy patients [43].
Femoral to femoral access is preferred for VAECMO 
because insertion is faster and easier in cardiogenic shock 
patients. 
Although depends on the indication and type of ECMO, 
management based on circuit and patient related factors. 
Anticoagulation is needed, with a target value ACT or aPTT, 
to maintain the blood flow in circuit. Hemodynamics is 
important especially in VV-ECMO, inotropes, vasodilators; 
blood volume replacement may be needed. Lung protective 
strategies are used with minimizing support of mechanical 
ventilator to achieve lung recovery. Minimal to heavy 
sedation is required according to the stage of the procedure. 
Positioning and activity, infection control, renal replacement, 
nutrition and temperature management require special 
attention.
ECMO is a bridge to; recovery till the resolution of 
underlying reversible cause (for example; resolve of 
thrombus in massive pulmonary embolism with severe 
hypoxemia), implantable circulatory support ventricular 
assist device (VAD) or transplantation of heart or lung 
(Table III).
Table III. Indications and contraindications for VA-ECMO
Indications vor VA-ECMO Contraindications for VA-ECMO
1-  Inadequate tissue perfusion manifested as htpotension and 
low cardiac output despite adequate vascular volume
2-  Shock persists despite volume administration, 
inotropes and vasoconstrictors and intraaortic balloon 
counterpulsation if appropriate
3-  Typical causes: Acute Myocardial infarction, myocarditis, 
peripartum cardiomyopathy, decompensated chronic heart 
failure, post cardiotomy shock.
4-  Septic Shock is considered as an indication in some 
centers.
5-  Biventricular failure, refractory malignant arrhythmias, 
heart failure with severe pulmonary failure
Absolute
1-  Prolonged CPR without adequate tissue perfusion
2-  Unrecoverable heart and not a candidate for transplant or 
VAD
3-  Advanced age
4-  Chronic organ dysfunction (emphysema, cirrhosis, renal 
failure)
5-  Compliance (financial, cognitive, psychiatric, or social 
limitations)
Relative
1-  Contraindication for anticoagulation
2-  Advanced age
3-  Obesity
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There is no absolute contraindication. Each cause depends on 
every patient individually with respect to risks and benefits. 
However, conditions associated with poor outcome despite 
ECMO can be considered as contraindications (Table IV).
Table IV. Indications and contraindications for VV-ECMO
Indications for VV-ECMO Contraindications for 
VV-ECMO
1- In hypoxic respiratory failure 
due to any cause ECLS should 
be considered when risk of 
mortality is 50% or greater and 
is indicatedwhen the risk of 
mortality is 80% or greater
1- Mechanical ventilation 
at high settings (FiO2 > 
.9, Pplat>30 for 7 days or 
more.
     a- 50% mortality risk is 
associated with a PaO2/FiO2 <150 
0n FiO2 > 90% and/or Murray 
shore 2-3
2- Major pjarmacologic 
immunosuppression 
(absolute neutrophil count 
<400/mm3)
     b- 80% mortality risk is 
associated with a PaO2/FiO2 
< 100 on FiO2 >90% and/or 
Murray score 3-4 despite optimal 
care for 6 hours or more.
3- CNS hemorrhage that is 
recent or expanding
2- CO2 retention on mechanic 
ventilation despite high Pplat. 
(>30 cm H2O)
4- Non-recoverable co-
morbidity such as major 
CNS damage or terminal 
malignancy
3- Severe airleak syndromes 5- Age: not specifically
4- Need for intubation in a 
patient on lung transplant list
5- Immediate cardiac or 
respiratory collapse PE, Blocked 
airway, Unresponsive to optimal 
care
Complications of ECMO
Problems could be related to the underlining disease or 
ECMO mechanics itself. The most common complication 
is hemorrhage [44]. Surgery required bleeding was reported 
up to 34% with VA-ECMO and 17% with VV-ECMO 
[45]. Mainly anticoagulation and hemodilution rarely 
catheter malposition cause bleeding [46].Bleeding may 
occur at cannula side as well as any side of the body and 
may increase mortality. Mostly pulmonary or intracerebral 
hemorrhage was reported thorough ARDS patients on 
ECMO [47]. Treatment requires stopping anticoagulants and 
infusion of platelets and clotting factors [46]. Hemolysis of 
blood in the circuit, thrombus or clot formation and systemic 
thromboembolism and cerebral infarction were also 
reported in the literature [48, 49].Catheter and circuit related 
infections and septic complications may be higher through 
patients on ECMO. Increased volume of distribution and 
filtering effect of membranous part of the circuit may alter 
serum concentration of drugs. Dose alterations may be 
necessary when narrow therapeutic drugs are administered 
[50].
Weaning from ECMO
ECMO support is decreased together with the recovery of 
underlying disease. When gas flow is minimum at lowest 
ventilatory settings with improving organ function, weaning 
protocol is started. As a rule weaning is started at levels 
less than 30% of total support. Ventilatory settings and 
vasopressor-inotropes are adjusted support is interrupted for 
a while and patient is checked for stability. This procedure is 
called as ‘trial off’. After a successful trial off, anticoagulant 
therapy is stopped and decannulation should be done. If 
patient seems to need ECMO further again, cannulas can be 
left 24 hours or more. Decannulation must performed after a 
successful trial off [43].
Prognosis
According to data reported by ELSO in January 2015, 
65.171patients received ECLS, of total 71% were weaned 
and59% were discharged or transferred [50]. Underlying 
cause for ECMO has an importance on survival. In a 
study, 67%ofARDS patients were reported to be treated 
successfully with ECMO and survival to hospital discharge 
was52 % [51]. CESAR study demonstrated that referral 
to an ECMO center significantly improves recovery and 
survival from severe ARDS [52]. H1N1-relatedARDS was 
shown to have lower hospital mortality when referred to an 
ECMO center (23.7% vs.52.5%) [53]. It has been shown 
that ECMO performed cardiopulmonary resuscitation was 
associated with increased survival with minimal neurologic 
impairment compared to conventional method [54].
In conclusion, experience with ECMO has been 
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improving with better survival rates and decreasing 
morbidity. Considering ECMO for patients with respiratory 
failure or heart failure when conventional therapies failed, if 
the underlying pathology is reversible or as a bridge to heart 
and/or lung transplantation is important.
Ultrasound in critical care
Advances in technology have led ultrasound (US) use 
through non-radiologist physicians at bedside. A non-
invasive, dynamic-real time tool that has no radiation risk 
may be valuable for critically ill for whom timely, efficient 
bedside diagnostics are essential. 
Critical care ultrasonography (CCUS) has utility 
for intensivist-performed, immediate diagnoses of life 
threatening diseases, with no need to transport patients to 
radiology departments or wait for radiologist or cardiologist 
on a consultative basis. Because of the principle of focused 
assessments, it differs from traditional US examinations 
where time-consuming full regional scans are performed. 
Additionally, the intensivist can repeat the examination 
to evaluate the effects of therapy and direct the management 
of the critical condition. Goal-directed and repeated US 
allows Intensive Care Unit (ICU) physician to diagnose and 
monitor the condition of the patient on a methodical basis.
Components of critical care ultrasonography
The American College of Chest Physicians/La Socie´te´ 
de Re´animation de Langue Franc¸aise Statement on 
Competence in Critical Care Ultrasonography (ACCP/SRLF 
Statement) defines 5 modules of CCUS: Cardiac: Basic and 
Advanced Levels, Thoracic: Lung and Pleura, Abdominal, 
Vascular Access and Vascular Diagnostic: Examination for 
Deep Venous Thrombosis(DVT) [55]
According to American Committee on Graduate Medical 
Education; US is a mandatory part of critical care fellowship 
training in the United States as from July 1, 2014 [56]. 
Consequently, CCUS and echocardiography should be 
an essential part of training of every ICU physician.
Thoracic ultrasonography
A recent field of CCUS is examination of the lung and 
pleura. Portability, absence of radiation, ability to repeat at 
bedside make lung US more applicable than chest x-ray or 
computed tomography (CT).
A variety of pathologies like pleural effusion, 
pneumothorax, atelectasis, pneumonia and alveolar-
interstitial syndrome can be detected easily and quickly 
by sonographic examination of thorax. Compared with 
chest x-ray, US has high sensitivity and specificity rates 
for detection of pleural [57, 58] and parenchymal [59-62]
diseases of lungs. (Table V) (Figures 5, 6, 7, 8, 9).
Table V. Sensitivity and specificity of US compared with chest 
x-ray
  Chest X ray (%)
sensitivity specificity
 US(%)
sensitivity specificity
Pleural 
effusion
39 85 92 93
Pneumothorax 50 99 100 98
Alveolar-
interstitial 
syndrome
60 100 98 88
Alveolar 
consolidation
68 95 93 100
Figure 5.  Normal lung US 
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Figure   6.    US  assessment of VCI diameter. Collapse  (decrease 
in VCI diameter more than 50%) with  inspiration  shows  fluid 
responsiveness
Figure 7.  Pleural fluid  seen in black. Also ondulations of pleural 
line during respiration in M mode on US are seen.
Figure 8. Air bronchogram  is shown as white lines/dots on US in 
a patient with pneumonia
Figure 9. A-Pneumothorax. Parallel horizontal lines above and 
below the pleural line, resemble a ‘barcode.(Barcode signs, 
stratosphere sign) B-Normal lung in B mode and in M mode, 
M-mode illustrating the ‘seashore sign.’ The pleural line divides 
the image in half: The motionless portion above the pleural line 
creates horizontal ‘waves,’ and the sliding line below it creates 
granular pattern, the ‘sand’seeshore sign.
On the other hand, there are some disadvantages of perfor-
ming thoracic US. It is notably that, almost all of the pat-
hologies detected on US are superficial. When it comes to 
deeper parenchymal pathologies, US may be an inadequate 
tool compared with CT. Since results are operator depen-
dent, different diagnoses between physicians may be confu-
sing. This disadvantage itself reflects the importance of an 
adequate, standard and supervised training program for ICU 
physicians. 
Abdominal ultrasound
Abdominal free fluid, causes of post-renal acute renal failure 
and however rarely, pathologies of retroperitoneum and 
major abdominal vessels can be detected early by focused 
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US assessments, especially in hemodynamically unstable 
critically ill. It has been shown in the critically ill that renal 
vasoconstriction can reduce renal blood flow to 50% of 
normal [63]. Daily monitoring renal perfusion via Doppler 
US in shock is a recent, ongoing research.
Transcranial Doppler (TCD)
Cerebral blood supply can be calculated using the Doppler 
US to support the diagnosis of brain death, vasospasm or 
ischemic stroke. TCD also helps to monitor the effects of 
therapeutic intervention of intracranial pathologies. It may 
help to diagnose brain death with a sensitivity of 76% and 
specificity of 74.3 % [64].
Ocular US
A direct relation has been documented between the 
subarachnoid space of the optic nerve and the chiasmal 
cistern of the brain. When ICP increases, cerebrospinal fluid 
flows towards the perineural subarachnoid space and results 
in expansion of the optic nerve sheath diameter (ONSD). 
Measurement of ONSD is useful to monitor intracranial 
pressure (ICP). A diameter of >5 mm has been shown to 
correlate with increased ICP shown on CT with a sensitivity 
of 100% and specificity 95%, respectively (Figure 10) [65].
Figure 10. Optic Nerve Sheath Diameter of 5,2 cm in  a 56 year-old 
male with intracranial hemorrhage  (N<5 mm)
Other uses of critical ultrasound ara başlık
Additionally US helps to detect; DVT, muscle wasting 
due to critical illness, edema of tracheal wall with smoke 
inhalation, position of endotracheal tube, gastric volume 
assessment in patients with nasoduodenal enteral feeding in 
critically ill.
It also can be used to guide vascular access, thoracentesis, 
pericardiocentesis, paracentesis, percutaneous tracheostomy 
and regional anesthesia. 
Critical care echocardiography 
According to the ACCP/SRLF Statement, critical care 
echocardiography (CCE) can be performed on two levels 
methodically: basic and advanced [55]. While basic CCE 
can be learned in a relatively short training period with a 
limited number of transthoracic echocardiography (TTE) 
views, advanced CCE requires an improved skill level in 
both TTE and transesophageal echocardiography (TEE) and 
a much longer duration of training. 
Reversible causes of shock or cardiac like cardiac 
tamponade, left ventricular failure, ventricular wall motion 
abnormalities, massive pulmonary embolism, infective 
endocarditis, intracardiac thrombi or aortic dissections 
can be detected immediately via ‘’ basic’’ or “focused” or 
“goal-directed” echocardiography, in critically ill patients.
(Figure 1) Additionally, fluid responsiveness of patients on 
admission can easily be determined in shock states. Goal-
directed echocardiography has been proven to, not only 
improve clinical diagnosis and but also management of 
acute critical illness (Table VI) [66].
Table VI. Basic TTE education
Pericardial space:  Assessment  of  pericardial effusion and tam-
ponade
Left  ventricular  (LV)  and  right  ventricular (RV)  dimensions 
and  function:     
   -  Cardiac  pump  failure 
   - Valvular  failure
   - Wall  motion  abnormalities  with  acute  coronary  syndrome
Acute  cor   pulmonale with massive pulmonary embolism
Severe  hypovolemia  with  end systolic effacement of  LV 
Inferior vena cava (IVC) diameter:    Assessment of fluid respon-
siveness and volume status.
Appropriate initial management strategy for shock: Need for va-
sopressors,   inotropes, fluids, thrombolytics 
Response to therapy:   Effects of fluid  resuscitation  or  throm-
bolytics on ventricular function.
Setting levels of   positive end expiratory pressure according to 
RV systolic  functions on mechanically ventilated
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A detailed assessment of stroke volume (SV),pulmonary 
pressures, left atrial pressure, valvular function and the great 
vessels (aorta and pulmonary artery) requires an advanced 
examination and recognition of an abnormal situation should 
prompt a detailed assessment by a cardiologist.
Since noninvasive estimation of LV filling pressures 
with echocardiography is possible, invasive placement of 
pulmonary artery catheter has decreased. A Doppler index, 
named E/Ea correlates significantly with invasively derived 
mean pulmonary capillary wedge pressure. Generally, an E/
Ea>10 is predictive of a mean pulmonary capillary wedge 
pressure above 15 mmHg with a sensitivity and specificity 
of 92 and 80 percent, respectively [67].
 Diameter of VCI may help to have an idea about volume 
status of critically ill. Although it does not accurately reflect 
central venous pressure; respiratory variability IVC diameter 
has been described as a noninvasive method for determining 
fluid responsiveness [68] (Figure 2) For example, If the VCI 
diameter is less than 2.1 cm and there is 50% collapse during 
respiration, it means that the patient has low volume status.
In conclusion, portable, repeatable, relatively 
inexpensive, painless, x-ray free and safe US examination 
is a practical approach to diagnose, manage and follow 
up of the critical illness. Sonographic examination should 
be a part of daily routine work of intensivists to improve 
morbidity and survival rates.
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